Latest News

In a groundbreaking study, Dr. Ye Zheng has led a discovery that total whole-arm chromosome losses can predict malignancy across various cancer types. This revolutionary finding provides a new framework for understanding cancer development and progression.

Researchers from Fred Hutch Cancer Center and MD Anderson Cancer Center have developed a novel technique that directly measures gene transcription activity from DNA, revealing that hyper-elevated levels of RNA Polymerase II (RNAPII) are linked to tumor aggressiveness.

Researchers from Fred Hutch Cancer Center and MD Anderson Cancer Center have discovered a new biomarker that can accurately predict the prognosis of meningiomas and breast cancers.

Congratulations to Ye Zheng for publishing a co-first author paper in Science!